Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call Transcript
Gilead Sciences, Inc. beats earnings expectations. Reported EPS is $-1.32, expectations were $-1.49. Gilead Sciences, Inc.
Source: insidermonkey.com
📰 Michael Yee News
Page 5 - Michael Yee News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michael Yee. Real-time updates on events, politics, business and more.
Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript
GILD earnings call for the period ending March 31, 2024.
United States Johanna Mercier Salveen Richter Goldman Sachs Merdad Parsey Chris Schott Jpmorgan Brian Abrahams
Source: yahoo.com
Gilead posts quarterly loss on acquisition charge, revenue rises 5%
(Reuters) -Gilead Sciences reported a first-quarter loss on Thursday after taking a $3.9 billion charge for its recent acquisition of liver drug developer CymaBay Therapeutics, while revenue rose 5% on higher HIV, oncology and liver disease treatment sales. For full-year 2024, Gilead said it still expects product sales of $27.1 billion to $27.5 billion, but lowered its earnings outlook to include the recent charge as well as incremental expenses related to the CymaBay deal. Wall Street analyst...
Source: yahoo.com
Biogen (BIIB) Q1 2024 Earnings Call Transcript
BIIB earnings call for the period ending March 31, 2024.
United States Czech Republic Mike Mcdonnell Piper Sandler Chris Viehbacher Salveen Richter Goldman Sachs
Source: fool.com
Moderna jumps as personalized cancer vaccine shows benefit in early study
Moderna shares rose 8% in morning trade on Tuesday after the companys individualized cancer vaccine developed with Merck showed positive response in an early-stage trial in patients with a type of...
United States Merck Keytruda Sriraj Kalluvila Michael Yee American Association Cancer Research Annual Meeting
Source: marketscreener.com
Moderna jumps as personalized cancer vaccine shows benefit in early study
(Reuters) - Moderna shares rose 8% in morning trade on Tuesday after the company's individualized cancer vaccine developed with Merck showed positive response in an early-stage trial in patients with a type of head and neck cancer. The vaccine is d...
United States Sriraj Kalluvila Merck Keytruda Michael Yee American Association Cancer Research Annual Meeting
Source: wsau.com
What's next for Pfizer, Moderna beyond their projected $51 billion in combined Covid vaccine sales this year
What's next for Pfizer, Moderna beyond their projected $51 billion in combined Covid vaccine sales this year : Rashtra News #Whats #Pfizer #Moderna #projected #billion #combined #Covid #vaccine #sales #year Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.Dado Ruvic | ReutersPfizer and Moderna
Source: rashtranews.com